Term Name: | nirogacestat dihydrobromide |
---|---|
Synonyms: | (2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]-pentanamide hydrobromide, (S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl) pentanamide dihydrobromide, N(2)-[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-N-(1-{1-[(2,2-dimethylpropyl)amino]-2-methylpropan-2-yl}-1H-imidazol-4-yl)-L-norvalinamide dihydrobromide, nirogacestat 2HBr, nirogacestat HBr, nirogacestat hydrobromide, Ogsiveo, PF 03084014 hydrobromide, PF 3084014 hydrobromide, PF-03084014 hydrobromide, PF-3084014 dihydrobromide |
Definition: | A hydrobromide salt obtained by reaction of nirogacestat with two equivalents of hydrobromic acid. |
Ontology: | ChEBI [CHEBI:229218] ( EBI ) |